Topics: Antipsychotics | Free Articles

Lurasidone (Latuda) was approved by the FDA for schizophrenia in October 2010 and is the 10th atypical antipsychotic in our toolbox. The key question is: does lurasidone have any advantages over existing agents, or is it just another “me-too” drug?

Topics: Antipsychotics

In what ways, if any, are cognitive problem a distinct feature of schizophrenia? And how can we use this information to guide treatment?

Check out this table for details on all of the atypical antipsychotics you commonly prescribe. Information in this table is on the June CME Test, so please read it with the rest of this issue's content.

Topics: Antipsychotics

Dr. Carpenter, you are a member of the DSM-5 work group that is considering risk syndrome for first psychosis, or what is now called “attenuated psychosis syndrome” as a new diagnosis in the manual.

Topics: Bipolar Disorder | Depressive Disorder

A combination of clinical lore and some studies have led many psychiatrists to believe that it is crucial to screen depressed patients for subtle signs of “bipolarity.”